Circulating Tumor Cells in Breast Cancer Patients
Author Information
Author(s): Holly Graves, Brian J. Czerniecki
Primary Institution: Hospital of the University of Pennsylvania
Hypothesis
What is the role of circulating tumor cells (CTCs) in breast cancer prognosis and disease progression?
Conclusion
Circulating tumor cells are a poor prognostic marker in metastatic breast cancer and may also indicate a poorer prognosis in early breast cancer.
Supporting Evidence
- CTCs are found in the blood of breast cancer patients but not in those with benign disease.
- Presence of CTCs is associated with poorer prognosis in both early and metastatic breast cancer.
- Studies suggest that CTC levels may guide changes in therapy.
Takeaway
Doctors are studying tiny cancer cells that float in the blood to see if they can help predict how bad breast cancer will be.
Methodology
The study reviews various methodologies for detecting circulating tumor cells and their prognostic implications in breast cancer.
Limitations
The study primarily focuses on the prognostic role of CTCs and may not cover all aspects of breast cancer treatment.
Participant Demographics
The study includes breast cancer patients, with a focus on both early and metastatic stages.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website